These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 22706665

  • 1. Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma.
    Li L, Jin R, Zhang X, Lv F, Liu L, Liu D, Liu K, Li N, Chen D.
    Hepatology; 2012 Oct; 56(4):1380-90. PubMed ID: 22706665
    [Abstract] [Full Text] [Related]

  • 2. Reduced nucleic ZHX2 involves in oncogenic activation of glypican 3 in human hepatocellular carcinoma.
    Luan F, Liu P, Ma H, Yue X, Liu J, Gao L, Liang X, Ma C.
    Int J Biochem Cell Biol; 2014 Oct; 55():129-35. PubMed ID: 25195714
    [Abstract] [Full Text] [Related]

  • 3. A functional screening identifies five microRNAs controlling glypican-3: role of miR-1271 down-regulation in hepatocellular carcinoma.
    Maurel M, Jalvy S, Ladeiro Y, Combe C, Vachet L, Sagliocco F, Bioulac-Sage P, Pitard V, Jacquemin-Sablon H, Zucman-Rossi J, Laloo B, Grosset CF.
    Hepatology; 2013 Jan; 57(1):195-204. PubMed ID: 22865282
    [Abstract] [Full Text] [Related]

  • 4. Glypican-3 promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through ERK signaling pathway.
    Wu Y, Liu H, Weng H, Zhang X, Li P, Fan CL, Li B, Dong PL, Li L, Dooley S, Ding HG.
    Int J Oncol; 2015 Mar; 46(3):1275-85. PubMed ID: 25572615
    [Abstract] [Full Text] [Related]

  • 5. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
    Wang Z, Ge L, Wang M, Carr BI.
    J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619
    [Abstract] [Full Text] [Related]

  • 6. Long noncoding RNA glypican 3 (GPC3) antisense transcript 1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3.
    Zhu XT, Yuan JH, Zhu TT, Li YY, Cheng XY.
    FEBS J; 2016 Oct; 283(20):3739-3754. PubMed ID: 27573079
    [Abstract] [Full Text] [Related]

  • 7. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling.
    Midorikawa Y, Ishikawa S, Iwanari H, Imamura T, Sakamoto H, Miyazono K, Kodama T, Makuuchi M, Aburatani H.
    Int J Cancer; 2003 Feb 10; 103(4):455-65. PubMed ID: 12478660
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of glypican-3 expression via RNA interference influences the growth and invasive ability of the MHCC97-H human hepatocellular carcinoma cell line.
    Ruan J, Liu F, Chen X, Zhao P, Su N, Xie G, Chen J, Zheng D, Luo R.
    Int J Mol Med; 2011 Oct 10; 28(4):497-503. PubMed ID: 21617840
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of antiglypican-3 therapy as a promising target for amelioration of hepatic tissue damage in hepatocellular carcinoma.
    Zaghloul RA, El-Shishtawy MM, El Galil KH, Ebrahim MA, Metwaly AA, Al-Gayyar MM.
    Eur J Pharmacol; 2015 Jan 05; 746():353-62. PubMed ID: 25449037
    [Abstract] [Full Text] [Related]

  • 10. Glypican-3 immunocytochemistry in liver fine-needle aspirates : a novel stain to assist in the differentiation of benign and malignant liver lesions.
    Kandil D, Leiman G, Allegretta M, Trotman W, Pantanowitz L, Goulart R, Evans M.
    Cancer; 2007 Oct 25; 111(5):316-22. PubMed ID: 17763368
    [Abstract] [Full Text] [Related]

  • 11. Expression of glypican 3 enriches hepatocellular carcinoma development-related genes and associates with carcinogenesis in cirrhotic livers.
    Liu X, Wang SK, Zhang K, Zhang H, Pan Q, Liu Z, Pan H, Xue L, Yen Y, Chu PG.
    Carcinogenesis; 2015 Feb 25; 36(2):232-42. PubMed ID: 25542894
    [Abstract] [Full Text] [Related]

  • 12. The expression profile of glypican-3 and its relation to macrophage population in human hepatocellular carcinoma.
    Takai H, Kato A, Kato C, Watanabe T, Matsubara K, Suzuki M, Kataoka H.
    Liver Int; 2009 Aug 25; 29(7):1056-64. PubMed ID: 19141032
    [Abstract] [Full Text] [Related]

  • 13. Expression profile and prognostic value of glypican-3 in post-operative South Korean hepatocellular carcinoma patients.
    Jeon Y, Kim H, Jang ES, Hong S, Kim JW, Yoon YS, Cho JY, Han HS, Jeong SH.
    APMIS; 2016 Mar 25; 124(3):208-15. PubMed ID: 26764243
    [Abstract] [Full Text] [Related]

  • 14. [Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells].
    Li BD, Zhao QC, Zhu YT, Zhang FQ, Dou KF.
    Zhonghua Wai Ke Za Zhi; 2006 Apr 01; 44(7):458-62. PubMed ID: 16772080
    [Abstract] [Full Text] [Related]

  • 15. Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more.
    Kandil DH, Cooper K.
    Adv Anat Pathol; 2009 Mar 01; 16(2):125-9. PubMed ID: 19550373
    [Abstract] [Full Text] [Related]

  • 16. Hepatitis B virus X protein upregulates Lin28A/Lin28B through Sp-1/c-Myc to enhance the proliferation of hepatoma cells.
    You X, Liu F, Zhang T, Lv N, Liu Q, Shan C, Du Y, Kong G, Wang T, Ye L, Zhang X.
    Oncogene; 2014 Jan 23; 33(4):449-60. PubMed ID: 23318446
    [Abstract] [Full Text] [Related]

  • 17. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
    Chen YL, Uen YH, Li CF, Horng KC, Chen LR, Wu WR, Tseng HY, Huang HY, Wu LC, Shiue YL.
    Ann Surg Oncol; 2013 Nov 23; 20(12):4041-54. PubMed ID: 22911364
    [Abstract] [Full Text] [Related]

  • 18. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
    Sohn BH, Park IY, Lee JJ, Yang SJ, Jang YJ, Park KC, Kim DJ, Lee DC, Sohn HA, Kim TW, Yoo HS, Choi JY, Bae YS, Yeom YI.
    Gastroenterology; 2010 May 23; 138(5):1898-908. PubMed ID: 20038433
    [Abstract] [Full Text] [Related]

  • 19. CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma.
    Pannem RR, Dorn C, Ahlqvist K, Bosserhoff AK, Hellerbrand C, Massoumi R.
    Carcinogenesis; 2014 Feb 23; 35(2):461-8. PubMed ID: 24104553
    [Abstract] [Full Text] [Related]

  • 20. CSIG promotes hepatocellular carcinoma proliferation by activating c-MYC expression.
    Cheng Q, Yuan F, Lu F, Zhang B, Chen T, Chen X, Cheng Y, Li N, Ma L, Tong T.
    Oncotarget; 2015 Mar 10; 6(7):4733-44. PubMed ID: 25749381
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.